COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic

Different pharmacotherapeutics have been introduced, and then stopped or continued, for the treatment of SARS-CoV-2. We evaluated the risks associated with mortality from SARS-CoV-2 infection. METHODS: Data was concurrently or retrospectively captured on COVID-19 hospitalized patients from 6 regiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Destache, Christopher J., Ahmad, Faran, Rajendrapasad, Sanu, Loranger, Austin, Pruett, William, Jagan, Nikhal, Krajicek, Bryan, Schmidt, David, Quimby, David, Velagapudi, Manasa, Boldt, Dayla, Hayes, Sarah, Anthone, Jennifer, Kessel, Brittney, Vivekanandan, Renuga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326520/
https://www.ncbi.nlm.nih.gov/pubmed/35893707
http://dx.doi.org/10.3390/pharmacy10040069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326520/
https://www.ncbi.nlm.nih.gov/pubmed/35893707
http://dx.doi.org/10.3390/pharmacy10040069

Ejemplares similares